Vitamin D Testing Market

The Vitamin D Testing Market is valued at USD 1175.5 Bn in 2026 and is projected to reach USD 2107.8 Bn, growing at a CAGR of 9% by 2033.

Increased Prevalence of Vitamin D Deficiency, and Related Diseases to Drive Vitamin D Testing Market Growth

Vitamin D, a fat-soluble vitamin, is a vital nutrient for people of all age groups and involved in numerous key functions in the human body. The biological roles of vitamin D comprise promoting calcium uptake by osteocytes for strong bones and joints, fortifying teeth, boosting immunity, elevating nervous system activity, ensuring brain power, maximal lung capacity and augmented heart health. Vitamin D also augments kidney functions, uplifts liver wellness by maintaining proper pH of blood, aside from controlling thyroid gland operations. Thus, vitamin D deficiency causes a host of health anomalies. Growing awareness regarding this is accountable for the rise of vitamin D testing market. The surging number of patients suffering from chronic disease along with vitamin D deficiency, rising per capita income of people, an increasing number of the geriatric population globally, and prevalence of improved healthcare infrastructure will largely boost the growth of the vitamin D testing market during the forecast period.

Increased demand for point-of-care testing, as well as developing trends in homecare testing, will provide numerous chances for the expansion of the vitamin D testing market over the forecast period. Vitamin D deficiency is a major public health problem in all age groups worldwide, even in low-latitude areas where it was widely considered that UV exposure was sufficient to avoid this deficit, and in industrialised countries where vitamin D fortification has been in place for years. Low vitamin D levels affect around 1 billion people of all ethnicities and ages due to chronic disease, use of sunscreen, inadequate dietary sources, and malabsorption. The increase in this number will favour the growth of vitamin D testing market in future.

The increased frequency of vitamin D insufficiency, as well as the rising prevalence of related disorders such as osteoporosis and inflammatory bowel disease (IBD), are among the key causes driving up demand for this technique. The global prevalence of IBD has been found to be 396 cases per 100,000 people per year. This large patient population suffering from vitamin D deficiency seeks medical attention for vitamin D deficiency treatment, resulting in an increasing economic burden. This eventually led to increasing activities for a number of vitamin D awareness programs by the government and other for-profit and non-profit groups. This is also likely to

25-Hydroxy Vitamin D Test Sought-after in Vitamin D Testing Market for Improved Accuracy

The 25-hydroxy vitamin D test led global vitamin D testing market in 2021 and is expected to continue to do so during the study period due to the availability of various commercial testing solutions. The most prevalent is 25-hydroxyvitamin vitamin D deficiency, abbreviated as 25(OH)D. The gold standard of vitamin D assays in determining the level of 25-hydroxy vitamin D. The increased prevalence of vitamin D deficiency and insufficiency is increasing demand for this testing around the world, sustaining this segment's segmental domination. The diverse application of 25-hydroxy vitamin D for nutritional assessment has aided in the expansion of this industry. With the convenience of testing with blood samples, this is the most popular testing method among medical practitioners.

North America’s Dominance Intact, Commercialisation of Vitamin D Tests Picks up in Asia Pacific

North America will account for the largest revenue share in the global vitamin D testing market in the forecast period and is expected to maintain its dominance during the forecast period, owing to rising healthcare spending, the presence of streamlined facilities, and the wide availability of at-home testing kits in the region. Strong market presence, well-established healthcare infrastructure, increased demand for minimally invasive testing, and the high prevalence of vitamin D insufficiency in North America are all likely to fuel revenue growth in this regional market. The rising prevalence of chronic renal disease is driving up the demand for 1,25-dihydroxy vitamin D testing. According to the United States Department of Health and Human Services, roughly 15.0 percent of US adults had CKD by 2021. As a result, the adoption rate of vitamin D diagnostic products is increasing, strengthening market expansion in this area.

Asia Pacific is predicted to grow at the fastest revenue rate during the forecast period due to an expanding aging population, rapid urbanisation, commercialisation of innovative procedures, and growing healthcare spending in developing countries like India, China, and Japan. In India, in 2020 it is believed that 490 million people are vitamin D deficient. With countries like Tunisia, Afghanistan, and Pakistan have a high rate of people with vitamin D deficiency. Growing investments by regional market players, commercialisation of vitamin D tests in Japan and China, rising life expectancy, high incidence of vitamin D deficiency, availability of health screening tests, and the presence of strong medical supply chains are expected to drive revenue growth in vitamin D testing market of Asia Pacific. Developing healthcare infrastructure, as well as increased adoption of these products in Chinese, and Japanese markets, is fuelling this region's rapid rise.

In May 2020, Abbott announced the availability of ID NOW in the United States, a point-of-care fast test that offers results in minutes rather than days or weeks. In March 2020, Thermo Fisher Scientific Inc. announced the availability of the Cascadion SM Clinical Analyzer for the Cascadion SM 25-hydroxy vitamin D assay in the United States in order to enhance its brand presence.

Few of the players in the vitamin D testing Market include:

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Thermo Fisher Scientific
• Beckman Coulter (Danaher Corporation)
• bioMérieux S.A.
• Quidel Corporation
• DiaSorin S.p.A.
• Agilent Technologies, Inc.
• PerkinElmer, Inc.
• Bio Rad Laboratories, Inc.
• Eurofins Scientific
• Sysmex Corporation
• Tosoh Corporation
• Quest Diagnostics

Global Vitamin D Testing Market is Segmented as Below:

By Test

• 25-Hydroxy D Vitamin
• 1,25-Dihydroxy D Vitamin

By Technique

• Radioimmunoassay
• ELISA
• HPLC
• LC-MS
• Others

By Patient

• Adult
• Paediatric

By Indication

• Osteoporosis
• Rickets
• Thyroid Disorders
• Malabsorption
• Vitamin D Deficiency
• Others

By End-User

• Hospitals
• Diagnostic Laboratories
• Home Care
• Point of Care
• Others

By Region

• North America
• Europe
• Asia Pacific
• LAMEA